Analytica 2020
The International Trade Fair for Laboratory Technology, Analysis, Biotechnology and Analytica Conference 2020 will take place in the International Congress Center (ICM), Munich, Germany, from 31 March to 3 April 2020.
Image Credit: f11photo/stock.adobe.com
The International Trade Fair for Laboratory Technology, Analysis, Biotechnology and Analytica Conference 2020 will take place in the International Congress Center (ICM), Munich, Germany, from 31 March to 3 April 2020.
From doping control to the detection of antibiotic-resistant germs to artificial intelligence (AI) in the laboratory, the Analytica conference reflects the entire spectrum of modern analysis. Attention increasingly rests on digitization in analytical disciplines: What do materials scientists use artificial intelligence methods for? How do physicians handle the increasing flood of data? What digital techniques can be used to optimize the monitoring of industrial processes? These and many other questions are being discussed by renowned researchers from around the world at the Analytica conference.
In addition to the overarching focus on digitalization, the conference agenda covers a wide range of current topics. The subject of doping control will be prominent with the Summer Olympic Games in Tokyo on the horizon. The wide variety of performance-enhancing substances-ranging from small inorganic substances to large biomolecules-are constantly changing and analytical techniques are in a constant race to keep up, making doping an exciting topic to cover.
The basis of the Analytica conference continues to be the numerous new developments in instrumental analysis. Thus, there are dedicated sessions on chromatography and mass spectrometry, spectroscopy, microscopy, and electroanalysis covering recent advancements and what the future holds for those techniques. A further session has been organized jointly by the “Pharmaceutical and Chemical Group” from Merck and the diagnostics company Immundiagnostik and will feature a series of lectures on biotechnologically produced active pharmaceutical ingredients. The importance of analysis for the pharmaceutical and healthcare sector is a major topic of interest at Analytica.
The multifaceted programme, organized by the Association of German Chemists (Gesellschaft Deutscher Chemiker, GDCh), the Society for Biochemistry and Molecular Biology (Gesellschaft für Biochemie und Molekularbiologie, GBM), and the German Society for Clinical Chemistry and Laboratory Medicine (Deutsche Gesellschaft für Klinische Chemie und Laboratoriumsmedizin, DGKL), invites you to look beyond your own horizons and let yourself be inspired by colleagues from other analytical disciplines.
The Analytica conference offers a great opportunity to exchange experience with your peers-and in the age of digitization and digitalization, this is more important than ever. Despite the many digital techniques and extremely helpful methods of AI, the knowledge, inventiveness, and, last but not least, intuition of experienced analysts will remain irreplaceable in the future. The challenge is to combine human expertise with the capabilities of machines. At the Analytica conference in Munich from 31 March to 3 April 2020, visitors can learn how this is already being done today and what opportunities this will open up for the analysis of tomorrow.
The Analytica conference takes place in the ICM in the immediate vicinity of the exhibition halls and is free for all Analytica visitors. For more information, please visit www.analytica.de/conference
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
